Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AMRI is set to merge its two departments, Discovery R&D and Discovery Chemistry departments worldwide to form a Global Drug Discovery organization, which will be led Bruce Sargent, senior vice president, drug discovery.
Subscribe to our email newsletter
AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for the healthcare companies.
AMRI president and CEO Thomas D’Ambra said that they believe that combining all of their discovery capabilities in biology and discovery chemistry under the direction of Sargent will further enhance AMRI’s ability to generate significant value for our customers and stakeholders.